Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification

Arthritis and Rheumatism

Volumn 44, Issue 5, 2001, Pages 1071-1081

  Johnson, Kristen ^a   Hashimoto, Sanshiro ^b   Lotz, Martin ^b   Pritzker, Kenneth ^c   Goding, James ^d   Terkeltaub, Robert ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c MOUNT SINAI HOSPITAL   (Canada)

^d MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; DEXAMETHASONE; GLYCEROL 2 PHOSPHATE; GLYCOPROTEIN; HYDROXYAPATITE; INORGANIC PYROPHOSPHATASE; NUCLEOTIDE PYROPHOSPHATASE; PHOSPHODIESTERASE; PYROPHOSPHATE;

APOPTOSIS; ARTICLE; CALCIFICATION; CARTILAGE MATRIX; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; KNEE MENISCUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGING; AUTOCRINE MOTILITY FACTOR; BIOLOGICAL MARKERS; CALCINOSIS; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCALCINOSIS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOPROTEINS; HUMANS; ISOENZYMES; KNEE JOINT; MEMBRANE GLYCOPROTEINS; MULTIENZYME COMPLEXES; OSTEOARTHRITIS, KNEE; PHOSPHATES; PHOSPHODIESTERASE I; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES; TRANSFECTION;

EID: 0035026555     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200105)44:5<1071::AID-ANR187>3.0.CO;2-3     Document Type: Article

References (52)

1. Ryan LM, McCarty DJ. Calcium pyrophosphate crystal deposition disease, pseudogout, and articular chondrocalcinosis. In: Koopman W, editor. Arthritis and allied conditions: a textbook of rheumatology. 13th ed. Baltimore: Williams & Wilkins; 1997. p. 2103-26.
2. Halverson PB, McCarty D. Basic calcium phosphate (apatite, octacalcium phosphate, tricalcium phosphate) crystal deposition diseases; calcinosis. In: Koopman W, editor. Arthritis and allied conditions: a textbook of rheumatology. 13th ed. Baltimore: Williams & Wilkins; 1997. p. 2127-46.
3. Derfus B, Kranendonk S, Camacho N, Mandel N, Kushnaryov V, Lynch K, et al. Human osteoarthritic cartilage matrix vesicles generate both calcium pyrophosphate dihydrate and apatite in vitro. Calcif Tissue Int 1998;63:258-62.
4. Ryan LM, McCarty DJ. Understanding inorganic pyrophosphate metabolism: toward prevention of calcium pyrophosphate dihydrate crystal deposition. Ann Rheum Dis 1995;54:939-41.
5. Johnson K, Vaingankar S, Chen Y, Moffa A, Goldring MB, Sano K, et al. Differential mechanisms of inorganic pyrophosphate production by plasma cell membrane glycoprotetn-1 and B10 in chondrocytes. Arthritis Rheum 1999;42:1986-97.
6. Anderson HC. Molecular biology of matrix vesicles. Clin Orthop 1995;314:266-80.
7. Hashimoto S, Ochs RL, Rosen F, Quach J, McCabe G, Solan J, et al. Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci U S A 1998;95:3094-9.
8. Kirsch T, Nah HD, Shapiro IM, Pacifici M. Regulated production of mineralization-competent matrix vesicles in hypertrophic chondrocytes. J Cell Biol 1997;137:1149-60.
9. Hsu HHT, Anderson HC. Evidence of the presence of a specific ATPase responsible for ATP-initiated calcification by matrix vesicles isolated from cartilage and bone. J Biol Chem 1996;271: 26383-8.
10. Kouri JB, Aguilera JM, Reyes J, Lozoya KA, Gonzalez S. Apoptotic chondrocytes from osteoarthrotic human articular cartilage and abnormal calcification of subchondral bone. J Rheumatol 2000;27:1005-19.
11. Zenmyo M, Komiya S, Kawabata R, Sasaguri Y, Inoue A, Morimatsu M. Morphological and biochemical evidence for apoptosis in the terminal hypertrophie chondrocytes of the growth plate. J Pathol 1996;180:430-3.
12. Johnson K, Moffa A, Pritzker K, Chen Y, Goding J, Terkeltaub R. Matrix vesicle plasma cell membrane glycoprotein-1 (PC-1) regulates mineralization by murine osteoblastic MC3T3 cells. J Bone Min Res 1999;14:883-92.
13. Johnson K, Jung AS, Murphy A, Andreyev A, Dykens J, Terkeltaub R. Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization. Arthritis Rheum 2000;43:1560-70.
14. Rosenthal AK, McCarty BA, Cheung HS, Ryan LM. A comparison of the effect of transforming growth factor β1 on pyrophosphate elaboration from various articular tissues. Arthritis Rheum 1993;36:534-42.
15. Cardenal A, Masuda I, Haas AL, McCarty DJ. Specificity of a porcine 127-kd nucleotide pyrophosphohydrolase for articular tissues. Arthritis Rheum 1996;39:245-51.
16. Goding JW. Ecto-enzymes: physiology meets pathology. J Leukoc Biol 2000;67:285-311.
17. Goding J, Terkeltaub R, Maurice M, Deterre P, Sali A, Belli S. Ecto-phosphodiesterase/pyrophosphatase of lymphocytes and nonlymphoid cells: structure and function of the PC-1 family, Immunol Rev 1998;161:11-26.
18. Lotz M, Rosen F, McCabe C, Quach J, Blanco F, Dudler J, et al. Interleukin 1 beta suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes. Proc Natl Acad Sci U S A 1995;92:10364-8.
19. Kawagoe H, Stracke ML, Nakamura H, Sano K. Expression and transcriptional regulation of the PD-Ia/autotaxin gene in neuroblastoma. Cancer Res 1997;57:2516-21.
20. Stracke ML, Clair T, Liotta LA. Autotaxin, tumor motility-stimulating exophosphodiesterase. Adv Enzyme Regul 1997;37: 135-44.
21. Lorenzo P, Neame P, Sommarin Y, Heinegard D. Cloning and deduced amino acid sequence of a novel cartilage protein (CILP) identifies a proform including a nucleotide pyrophosphohydrolase. J Biol Chem 1998;273:23469-75.
22. Lorenzo P, Bayliss MT, Heinegard D. A novel cartilage protein (CILP) present in the mid-zone of human articular cartilage increases with age. J Biol Chem 1998;273:23463-8.
23. Lorenzo P, Aman P, Sommarin Y, Heinegard D, The human CILP gene: exon/intron organization and chromosomal mapping. Matrix Biol 1999;18:445-54.
24. Masuda I, Halligan BD, Barbieri JT, Haas AL, Ryan LM, McCarty DJ. Molecular cloning and expression of a porcine chondrocyte nucleotide pyrophosphohydrolase. Gene 1997;197:277-87.
25. Masuda I, Hamada J-I, Haas A, Ryan L, McCarty D. A unique ectonucleotide pyrophosphohydrolase associated with porcine chondrocyte-derived vesicles. J Clin Invest 1995;95:699-704.
26. Messner K, Gao J. The menisci of the knee joint: anatomical and functional characteristics, and a rationale for clinical treatment. J Anat 1998;193:161-78.
27. Hashimoto S, Takahashi K, Ochs RL, Coutts RD, Amiel D, Lotz M. Nitric oxide production and apoptosis in cells of the meniscus during experimental osteoarthritis. Arthritis Rheum 1999;42:2123-31.
28. Hashimoto S, Setareh M, Ochs RL, Lotz M. Fas/Fas ligand expression and induction of apoptosis in chondrocytes. Arthritis Rheum 1997;40:1749-55.
29. Hashimoto S, Ochs RL, Komiya S, Lotz M. Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Arthritis Rheum 1998;41:1632-8.
30. Belli SI, Goding JW. Biochemical characterization of human PC-1, an enzyme possessing alkaline phosphodiesterase I and nucleotide pyrophosphatase activities. Eur J Biochem 1994;226:433-43.
31. Solan JL, Deftos LJ, Goding JW, Terkeltaub RA. Expression of the nucleoside triphosphate pyrophosphohydrolase PC-1 is induced by basic fibroblast growth factor (bFGF) and modulated by activation of the protein kinase A and C pathways in osteoblastlike osteosarcoma cells. J Bone Miner Res 1996;11:183-92.
32. Reginato AM, Iozzo RV, Jimenez SA. Formation of nodular structures resembling mature articular cartilage in long-term primary cultures of human fetal epiphyseal chondrocytes on a hydrogel substrate. Arthritis Rheum 1994;37:1338-49.
33. Clancy R. Nitric oxide alters chondrocyte function by disrupting cytoskeletal signaling complexes. Osteoarthritis Cartilage 1999;7: 399-400.
34. Johnstone B, Hering TM, Caplan AI, Goldherg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 1998;238:265-72.
35. Bodine PV, Vernon SK, Komm BS. Establishment and hormonal regulation of a conditionally transformed preosteocytic cell line from adult human bone. Endocrinology 1996;137:4542-604.
36. Gori F, Thomas T, Hicok KC, Spelsberg TC, Riggs BL. Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J Bone Miner Res 1999;14:1522-35.
37. Cheng PT, Pritzker KP. The effect of calcium and magnesium ions on calcium pyrophosphate crystal formation in aqueous solutions. J Rheumatol 1981;8:772-82.
38. Cheng PT, Pritzker KP, Kandel RA, Reid A. Analytical scanning and transmission electron microscopy and x-ray microdiffractometry of calcium pyrophosphate dihydrate crystal deposits in tissues. Scan Electron Microsc 1983 (Pt 1):369-77.
39. Cheung HS, Ryan LM. Phosphocitrate blocks nitric oxide-induced calcification of cartilage and chondrocyte-derived apoptotic bodies. Osteoarthritis Cartilage 1999;7:409-12.
40. Clair T, Lee HY, Liotta LA, Stracke ML. Autotaxin is an exoenzyme possessing 5′-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities. J Biol Chem 1997;272: 996-1001.
41. Marinescu RC, Nyce K, Serrano de la Peña L, Overhauser J, Williams CJ. Exclusion of the gene for human cartilage intermediate layer protein in currently mapped calcium pyrophosphate dihydrate deposition syndromes. Arthritis Rheum 1999;42: 2139-44.
42. Kirsch T, Swoboda B, Nah H. Activation of annexin II and V expression, terminal differentiation, mineralization and apoptosis in human osteoarthritic cartilage. Osteoarthritis Cartilage 2000;8: 294-302.
43. Bachner D, Ahrens M, Betat N, Schroder D, Gross G. Developmental expression analysis of murine autotaxin (ATX). Mech Dev 1999;84:121-5.
44. Bachner D, Ahrens M, Schroder D, Hoffmann A, Lauber J, Betat N, et al. BMP-2 downstream targets in mesenchymal development identified by subtractive cloning from recombinant mesenchymal progenitors (C3H10T1/2). Dev Dyn 1998;213:398-411.
45. Narisawa S, Frohlander N, Millan JL. Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia. Dev Dyn 1997;208:432-46.
46. Cheng PT, Pritzker KP. Pyrophosphate, phosphate ion interaction: effects on calcium pyrophosphate and hydroxyapatite crystal formation in aqueous solutions. J Rheumatol 1983;10:769-77.
47. Mandel GS, Halverson PB, Rathburn M, Mandel NS. Calcium pyrophosphate crystal deposition: a kinetic study using a type I collagen gel model. Scanning Microsc 1990;4:175-9.
48. Mandel N, Mandel G. Calcium pyrophosphate crystal deposition in model systems. Rheum Dis Clin North Am 1988;14:321-40.
49. Ryan LM, Rachow JW, McCarty DJ. Synovial fluid ATP: a potential substrate for the production of inorganic pyrophosphate. J Rheumatol 1991;18:716-20.
50. Okawa A, Nakamura I, Goto S, Moriya H, Nakamura Y, Ikegawa S. Mutation in Npps in a mouse model ot ossification of the posterior longitudinal ligament of the spine. Nat Genet 1998;19:271-3.
51. Sakamoto M, Hosoda Y, Kojimahara K, Yamazaki T, Yoshimura Y. Arthritis and ankylosis in twy mice with hereditary multiple osteochondral lesions: with special reference to calcium deposition. Pathol Int 1994;44:420-7.
52. Ho AM, Johnson MD, Kingsley DM. Role of the mouse ank gene in control of tissue calcification and arthritis. Science 2000;289: 265-70.